Half-year report · Q2

Period2024-04-01 → 2024-09-30
Filed2024-11-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥20.2bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥36.2bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥18.1bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income¥2.5bn2024-04-01 → 2024-09-30Cons.Operating income
Operating income¥1.5bn2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income¥2.4bn2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥1.7bn2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.3bn2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax¥2.4bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥2.3bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)¥1.9bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.2bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.1bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income¥1.9bn2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥2.1bn2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥84.4bnat 2024-09-30Cons.Assets
Total assets¥81.8bnat 2024-03-31Cons.Assets
Total assets¥79.6bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥9.1bnat 2024-09-30Cons.Liabilities
Total liabilities¥9.5bnat 2024-03-31Cons.Liabilities
Net assets / equity¥75.3bnat 2024-09-30Cons.Net assets
Net assets / equity¥72.3bnat 2024-03-31Cons.Net assets
Net assets / equity¥71.5bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥16.9bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥15.4bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥19.8bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥18.7bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥21.0bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥25.8bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow¥3.0bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥513m2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥490m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥1.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥7.2bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥4.6bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥732m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.5bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥731m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥35.392024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥40.082023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥38.542023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio89.2%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio88.4%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio89.9%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E00970-000LALreportable segmentrevenue2024-04-01 → 2024-09-30¥5.9bn
jpcrp040300-q2r_E00970-000LALreportable segmentrevenue external2024-04-01 → 2024-09-30¥5.9bn
jpcrp040300-q2r_E00970-000LALreportable segmentsegment profit2024-04-01 → 2024-09-30¥481m
jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segmentrevenue2024-04-01 → 2024-09-30¥14.3bn
jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segmentrevenue external2024-04-01 → 2024-09-30¥14.3bn
jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segmentsegment profit2024-04-01 → 2024-09-30¥2.1bn
—segment totalrevenue2024-04-01 → 2024-09-30¥20.2bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥20.2bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥2.5bn
jpcrp040300-q2r_E00970-000LALreportable segmentrevenue2023-04-01 → 2023-09-30¥5.0bn
jpcrp040300-q2r_E00970-000LALreportable segmentrevenue external2023-04-01 → 2023-09-30¥5.0bn
jpcrp040300-q2r_E00970-000LALreportable segmentsegment profit2023-04-01 → 2023-09-30¥420m
jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segmentrevenue2023-04-01 → 2023-09-30¥13.1bn
jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segmentrevenue external2023-04-01 → 2023-09-30¥13.1bn
jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segmentsegment profit2023-04-01 → 2023-09-30¥1.1bn
—segment totalrevenue2023-04-01 → 2023-09-30¥18.1bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥18.1bn
—segment totalsegment profit2023-04-01 → 2023-09-30¥1.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 518
ItemContextValueUnit
Independent auditors report consolidated (text)FilingDateInstantText · Plus
Audit firm1 consolidatedFilingDateInstant
Original text (Japanese)有限責任監査法人トーマツ
Cpa1 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)三澤 幸之助
Cpa2 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)杉本 健太郎
Number of submissionFilingDateInstant1
Net sales (5-year summary)Prior1YTDDuration18061000000JPY
Net sales (5-year summary)CurrentYTDDuration20210000000JPY
Net sales (5-year summary)Prior1YearDuration36213000000JPY
Ordinary income loss (5-year summary)Prior1YTDDuration2327000000JPY
Ordinary income loss (5-year summary)CurrentYTDDuration2354000000JPY
Ordinary income loss (5-year summary)Prior1YearDuration1691000000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YTDDuration2102000000JPY
Profit loss attributable to owners of parent (5-year summary)CurrentYTDDuration1931000000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YearDuration2186000000JPY
Comprehensive income (5-year summary)Prior1YTDDuration5021000000JPY
Comprehensive income (5-year summary)CurrentYTDDuration3701000000JPY
Comprehensive income (5-year summary)Prior1YearDuration6469000000JPY
Net assets (5-year summary)Prior1QuarterInstant71544000000JPY
Net assets (5-year summary)CurrentQuarterInstant75289000000JPY
Net assets (5-year summary)Prior1YearInstant72282000000JPY
Total assets (5-year summary)Prior1QuarterInstant79620000000JPY
Total assets (5-year summary)CurrentQuarterInstant84360000000JPY
Total assets (5-year summary)Prior1YearInstant81795000000JPY
Basic earnings loss per share (5-year summary)Prior1YTDDuration38.54
Basic earnings loss per share (5-year summary)CurrentYTDDuration35.39
Basic earnings loss per share (5-year summary)Prior1YearDuration40.08
Diluted earnings per share (5-year summary)Prior1YTDDuration-
Diluted earnings per share (5-year summary)CurrentYTDDuration-
Diluted earnings per share (5-year summary)Prior1YearDuration-
Equity to asset ratio (5-year summary)Prior1QuarterInstant0.899
Equity to asset ratio (5-year summary)CurrentQuarterInstant0.892
Equity to asset ratio (5-year summary)Prior1YearInstant0.884
Net cash provided by used in operating activities (5-year summary)Prior1YTDDuration-490000000JPY
Net cash provided by used in operating activities (5-year summary)CurrentYTDDuration2995000000JPY
Net cash provided by used in operating activities (5-year summary)Prior1YearDuration513000000JPY
Net cash provided by used in investing activities (5-year summary)Prior1YTDDuration-4578000000JPY
Net cash provided by used in investing activities (5-year summary)CurrentYTDDuration-1397000000JPY
Net cash provided by used in investing activities (5-year summary)Prior1YearDuration-7209000000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YTDDuration-731000000JPY
Net cash provided by used in financing activities (5-year summary)CurrentYTDDuration-732000000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YearDuration-1461000000JPY
Cash and cash equivalents (5-year summary)Prior1QuarterInstant20987000000JPY
Cash and cash equivalents (5-year summary)CurrentQuarterInstant19810000000JPY
Cash and cash equivalents (5-year summary)Prior1YearInstant18701000000JPY
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember56814093
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember56814093
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant56814093
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant56814093
Number of shares heldCurrentQuarterInstant_No1MajorShareholdersMember7843000
Shareholding ratioCurrentQuarterInstant_No1MajorShareholdersMember0.1437

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identityconsolidated 2024-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass